| Filed On | Filing |
|---|---|
| 29 Jan 2025 |
8-K: Other Events
Plaintiff: JORDAN LEAJAMES (MCCANN), Derivatively on Behalf of AMPIO |
| 15 Apr 2024 | 15-12G |
| 04 Apr 2024 | FORM 25 |
| 27 Mar 2024 | 10-K |
| 25 Mar 2024 |
8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Other Events
ENGLEWOOD, Colo., March 25, 2024 – Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company” or “Ampio”) today announced that its Board of Directors determined to voluntarily delist its common stock from the NYSE American and dere... |
| 04 Mar 2024 | EFFECT |
| 28 Feb 2024 |
8-K: Termination of a Material Definitive Agreement
On February 26, 2024, Ampio Pharmaceuticals, Inc. (the “Company”) provided a notice to H.C. Wainwright & Co., LLC to terminate that certain At The Marketing Offering Agreement, dated September 18, 2023, by and between the Company and H.C... |
| 28 Feb 2024 | S-8 POS |
| 28 Feb 2024 | S-8 POS |
| 28 Feb 2024 | POS AM |
| 28 Feb 2024 | RW |
| 15 Feb 2024 |
8-K: Regulation FD Disclosure
ENGLEWOOD, Colo., February 14, 2024 – Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company” or “Ampio”), a pre-revenue stage biopharmaceutical company focused on development of a potential treatment for osteoarthritis as part ... |
| 25 Jan 2024 |
8-K: Other Events
We have acted as legal counsel to Ampio Pharmaceuticals, Inc., a Delaware corporation (the “Company”), in connection with the transactions contemplated by that certain At The Market Offering Agreement, dated as of September 18, 2023 (the... |
| 25 Jan 2024 | 424B5 |
| 24 Jan 2024 | 424B5 |
| 11 Jan 2024 |
8-K: Regulation FD Disclosure
ENGLEWOOD, Colo., January 11, 2024 – Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company” or “Ampio”), a pre-revenue stage biopharmaceutical company focused on development of a potential treatment for osteoarthritis as part o... |
| 21 Dec 2023 | S-1 |
| 07 Dec 2023 | SC 13G/A |
| 14 Nov 2023 | 10-Q |
| 02 Nov 2023 |
8-K: Regulation FD Disclosure
Ampio Pharmaceuticals 1 Emerging Growth Conference November 02, 2023 iStock |
Loading...